Safety syringe maker wins $113 million judgment

By Jeremy Carroll
Assistant Managing Editor

Published: September 25, 2013 4:08 pm ET
Updated: September 25, 2013 4:09 pm ET

Related to this story

Topics Legal, Medical

A jury awarded Retractable Technologies Inc. more than $113 million after it determined a competitor attempted to obtain a monopoly in the plastic safety syringe market.

Retractable Technologies sued Becton, Dickinson and Co. (BD) in 2007, saying the manufacturer of medical devices had violated the company’s patents for a retractable syringe, created a monopoly on the market and used anticompetitive tactics to push out competition.

A jury dismissed most of the counts, including claims that BD had established a monopoly on the market, but agreed that the company did engage in anticompetitive conduct with the intent to acquire and maintain a monopoly in regards to safety syringes.

The jury also said BD engaged in false advertising under the Lanham Act. The judge in the case will rule on if those specific items deserve a financial payment as well.

“The company is very pleased with the verdict, and believes that it is a step toward opening the market to its innovative products,” said Retractable Technologies attorney Roy Hardin.

BD vowed to appeal the ruling.

“We’re disappointed with the portion of the verdict that favored [Retractable Technologies], and we believe this aspect of the verdict was erroneous,” said Jeffrey Sherman, senior vice president and general counsel, in a statement. “We will file an appeal at the earliest opportunity.”

BD told investors it would record a pretax charge of approximately $340 million (approximately $211 million after taxes and an estimated $1.06 per diluted share) in its 2013 fiscal fourth quarter results, because of the verdict.

In its original complaint, Retractable Technologies called BD the “nation’s dominate maker and seller of disposal syringes.”

Retractable Technologies said it invented a syringe that automatically retracted the needle after the injection is given and before it is withdrawn from the patient, eliminating concerns of health care workers accidently sticking themselves with the needle.

The VanishPoint syringe system is made of plastic and is spring-loaded.

Several years after that product was on the market, BD introduced the Integra syringe, which operated in a similar fashion as the VanishPoint syringe, Retractable Technologies alleged.

Retractable Technologies said BD employed various forms of exclusionary contracts with health care facilities in order to dominate the market. Under the contracts, facilities would be required to maintain a certain level of purchases through bundling of items, so they would not able to stray from one product, even if they could get it cheaper elsewhere, the complaint alleged.

Retractable Technologies also claimed BD caused or induced trade shows to bar and exclude Retractable’s sales staff from entering and demonstrating their products.

“For example, Retractable has been barred from one or more trade shows, even though the purpose of the shows was to demonstrate available safety technology to medical staff,” the complaint alleged. “Hospital and trade show personnel have explained the exclusion of Retractable’s sales personnel by saying their facility is under contract with BD, exclusive to BD, or standardized with BD.”

Retractable Technologies alleged that BD labeled several of their needle products as “safety” or “safe” even though they were no safer than traditional needles. That point is important because health care facilities are often willing to pay a higher price for “safety” products, which are sold in a separate sub-market of products.

The case is expected to be back in Texas District Court on Dec. 12.


Comments

Safety syringe maker wins $113 million judgment

By Jeremy Carroll
Assistant Managing Editor

Published: September 25, 2013 4:08 pm ET
Updated: September 25, 2013 4:09 pm ET

Post Your Comments


Back to story


More stories

MGS buying N.Y. medical molding plant from Hospira

April 17, 2014 10:19 pm ET

MGS Manufacturing Group is purchasing the Buffalo, N.Y., injection molding facility and related product line of Hospira Inc., effective July 1. Terms ...    More

No action yet, but opposition still brewing to medical device tax

April 11, 2014 1:29 pm ET

Indiana politicians are stepping up their game in attempts to get the much-maligned medical device tax repealed.    More

3D printing specialist buys Colorado injection molder

April 9, 2014 5:34 pm ET

ARC Group Worldwide Inc. is expanding its reach to plastic injection molding, tooling and magnesium injection molding with the acquisition of two...    More

Eldon James sees more growth in 2014

April 7, 2014 2:30 pm ET

Now settled in its new home, plastics processor Eldon James Co. forecasts sales growth of 40 percent during 2014, coming on top of a 20 percent climb ...    More

Market Reports

Thermoformed Packaging 2014 Market Review & Outlook North America

This in-depth report provides analysis and discussions of economic and political conditions, market trends, legislative/regulatory activity impacting supply and demand, business opportunities and threats, materials pricing, manufacturing technology, as well as strategies being implemented by thermoformed packaging companies. In addition, there are reviews of 25 leading thermoformers in the packaging segment, assessing their growth initiatives and performance metrics over 10 years.

Learn more

Automotive Market Review and Outlook 2014 The Americas

This 75-page report features in-depth analysis of the automotive industry for the Americas. It includes discussions of market trends, legislative/regulatory activity impacting production and threats as well as design strategies being implemented by the major automakers. Detailed charts and data tables outline North American automotive production over the last five years.

Learn more

Plastics Building & Construction Market Review and Outlook 2014 with MS Excel chart data

This report provides in-depth analysis of the plastic building and construction market for North America, including discussions of trends, opportunities, threats and the latest developments in construction trends that impact plastics processors.

Learn more

Upcoming Plastics News Events

May 6, 2014 - May 8, 2014Plastics in Medical Devices 2014

May 12, 2014 - May 12, 2014Plastics News Brazil Pharma Summit

September 10, 2014 - September 12, 2014Plastics Caps & Closures 2014

February 3, 2015 - February 7, 2015Plastics News Executive Forum 2015

More Events